Microneedle Drug Delivery Systems Market
Microneedle Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Component (Coated Microneedle Technology, Hollow Microneedle Technology, Solid Microneedle Technology and Other Components), Type, Material, Application, End User and By Geography
According to Stratistics MRC, the Global Microneedle Drug Delivery Systems Market is accounted for $5.89 billion in 2023 and is expected to reach $11.04 billion by 2030 growing at a CAGR of 9.4% during the forecast period. The devices for the regulated and effective transdermal delivery of medications, vaccines, and other therapeutic agents is known as the microneedle drug delivery systems market. The goal of microneedles, which are minimally invasive needles, is to make microchannels in the skin's outermost layer so that drugs and bioactive substances can be administered intra- or transdermally. They are used to provide painless vaccination, increasing vaccine coverage and making immunization more patient-friendly.
According to an article published by ACS, in May 2020, the researchers at the University of Pittsburgh Medical Center and the University of Pittsburgh tried to develop a microneedle array (MNA), a fingertip-sized patch with 400 microscopic needles that inject spiked protein fragments into the skin, where an immune response is most potent.
Market Dynamics:
Driver:
Enhancement of public health initiatives
With their painless and minimally intrusive drug delivery capabilities, microneedles hold enormous potential for transforming public health initiatives such as immunization campaigns. By providing a more comfortable and approachable option to traditional injections, these gadgets increase accessibility to immunization and reduce anxiety. Microneedles can promote increased vaccine acceptance and compliance by lessening the discomfort associated with needle injections, which will ultimately result in higher immunization coverage rates. Therefore, the goal of improving health outcomes and disease control is aligned with the deployment of microneedle drug delivery systems in public health programs, which is a driving force behind the development of this cutting-edge medical technology.
Restraint:
Expensive production of microneedles
These specialized gadgets need complex engineering, precise quality control, and the use of biocompatible materials in their creation and manufacturing. These elements limit the market potential by raising the cost of production. However, this cost can lead to increased prices for products that use microneedles. These expenses may restrict the adoption of the treatment by making it difficult for patients and healthcare providers to obtain care.
Opportunity:
Increasing drug absorption and bioavailability
Drug delivery is made more effective by the microchannels that are created in the skin by microneedles. Drugs can avoid the gastrointestinal system due to microneedles, which may result in a shorter duration of action and better bioavailability. This may lead to lower doses of more potent treatments that are more effective, lowering the possibility of adverse effects and enhancing patient outcomes. Furthermore, the capacity to augment drug absorption and bioavailability signifies a significant advancement in the domain of drug delivery, rendering microneedles a compelling choice for pharmaceutical corporations, healthcare professionals, and patients in search of enhanced therapeutic alternatives.
Threat:
Limited drug compatibility
Even though microneedles present a promising and user-friendly method of drug administration, not all drugs are appropriate for use with this technology. Microneedles' composition and design may limit the medications that can be used with them to those that have certain qualities, including the right molecular size, solubility, and stability. This constraint limits the types of drugs and biologics that may be delivered with microneedles in an efficient manner, which may prevent some essential drugs from benefiting from this novel delivery system. However, it can take some time and be expensive to build microneedle-based devices for particular medications.
Covid-19 Impact:
The government's lockdown methods and the hospital and clinic closures resulted in a disruption of care for people with chronic illnesses brought on by their lifestyle choices. Because of the increasing frequency of COVID-19 infections, businesses and academic institutions are concentrating more on developing fingertip-sized skin patches for pandemic medication administration. Thus, the adoption of microneedles for COVID-19 immunization affected the market's growth during the pandemic.
The coated microneedle technology segment is expected to be the largest during the forecast period
Coated microneedle technology segment is expected to hold largest share during the forecast period. With this cutting-edge technology, the surface of microneedles with biocompatible coatings can be coated for a variety of uses. These coatings can be made to improve the stability of sensitive chemicals, control the release of medications or therapeutic agents, or improve the shelf life of microneedle products. Additionally, due to the improved patient experience and efficacy, which is fueling the growth of the microneedle drug delivery systems industry.
The dermatology segment is expected to have the highest CAGR during the forecast period
Dermatology segment is estimated to witness lucrative growth. Microneedle technology is transforming dermatological treatments by providing a precise and minimally invasive way to administer drugs, skincare products, and cosmetic therapies. Furthermore, microneedle-based dermatological operations, also known as microneedling, can treat a variety of skin issues, including wrinkles, acne scars, pigmentation, and aging symptoms.
Region with largest share:
Over the course of the forecast period, North America is anticipated to hold the largest share of the market due to an increase in the prevalence of infectious, skin, and chronic diseases; a growth in the technological advancement of drug delivery systems; an increase in the adoption of highly advanced techniques and systems in the fabrication of microneedles. Additionally, to guarantee patient safety and product efficacy, the regulatory procedure involves stringent evaluations, clinical trials, and adherence to quality standards. The development and uptake of microneedle drug delivery systems in North America will continue to be influenced by government initiatives and regulations that support new and patient-friendly drug delivery technologies as well as the prioritization of public health.
Region with highest CAGR:
The Asia Pacific region is anticipated to have profitable growth during the forecast period as a result of the expanding pharmaceutical sector and the growing need for advanced drug delivery techniques. These initiatives center on improving the composition and structure of microneedles, refining drug delivery systems, and broadening the scope of uses in areas such as vaccination, dermatology, and chronic illness care. Moreover, innovation in the region is also being promoted by partnerships among government agencies and academic institutions.
Key players in the market
Some of the key players in Microneedle Drug Delivery Systems market include 3M, 3D-Micromac AG, Becton, Dickinson and Company, Candela Corporation, Clearside Biomedical, Inc., Corium Inc., Dermaroller GmbH, Dynatrace, Genex Technologies, Georgia Institute of Technology, Innoture Medical Technology Limited, LTS Lohmann Therapie-Systeme AG, Micron Biomedical Inc., Micropoint Technologies, My Life Technologies, NanoSmart Pharmaceuticals, Inc., Nitto Denko Corporation, PreCelleon Medical Inc., Rani Therapeutics, Raphas Co. Ltd, TheraJect Inc., Transdermal Technologies, Inc., Valeritas, Inc., Vaxess Technologies, Zosano Pharma and Zydis.
Key Developments:
In August 2023, Mind Medicine, a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced that it has entered into a license agreement with Catalent, a leader in enabling the development and supply of better treatments for patients worldwide, to access Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
In December 2022, Emergex looks to microneedle patches with Zosano Pharma acquisition. The assets acquired include intellectual property, license agreements, and manufacturing equipment. They also include Zosano’s proprietary microneedle array patch (MAP) intradermal drug delivery system, including a reusable applicator, solid coated microneedle array patch technology, product packaging, methods for formulation and microneedle coating, and specialized equipment, designed and built for clinical and commercial manufacture of the technology.
In November 2022, CGBio, a South Korean healthcare provider, launched a skin trouble care patch, CGDew Derma Regen, in its microneedle pipeline. These microneedle patches are made from a range of materials, such as silicon, titanium, stainless steel, and polymers, to improve the diffusivity of medications to the stratum corneum by forming pores on the skin that are smaller than a micron.
In October 2022, Emergex Vaccines Holding Limited acquired the assets of Zosano Pharma Corporation. The assets include intellectual property, license agreements, manufacturing equipment, Zosano’s proprietary microneedle array patch (MAP) intradermal drug delivery system, solid-coated microneedle array patch technology, methods for formulation and microneedle coating, and specialized equipment.
Components Covered:
• Coated Microneedle Technology
• Hollow Microneedle Technology
• Solid Microneedle Technology
• Other Components
Types Covered:
• Dissolving Microneedle Technology
• Porous Microneedles
• 3D-Printed Microneedles
• Hydrogel Microneedles
• Other Types
Materials Covered:
• Biodegradable Microneedle Materials
• Ceramics
• Metal
• Metal Alloys
• Polymer
• Silicon
• Other Materials
Applications Covered:
• Cancer Therapy
• Dermatology
• Hormone Delivery
• Insulin Delivery
• Oncology
• Pain Management
• Pediatric Medicine
• Transdermal Drug Delivery
• Vaccine Delivery
• Other Applications
End Users Covered:
• Pharmacies
• Hospitals
• Healthcare Providers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Microneedle Drug Delivery Systems Market, By Component
5.1 Introduction
5.2 Coated Microneedle Technology
5.3 Hollow Microneedle Technology
5.4 Solid Microneedle Technology
5.5 Other Components
6 Global Microneedle Drug Delivery Systems Market, By Type
6.1 Introduction
6.2 Dissolving Microneedle Technology
6.3 Porous Microneedles
6.4 3D-Printed Microneedles
6.5 Hydrogel Microneedles
6.6 Other Types
7 Global Microneedle Drug Delivery Systems Market, By Material
7.1 Introduction
7.2 Biodegradable Microneedle Materials
7.3 Ceramics
7.4 Metal
7.5 Metal Alloys
7.6 Polymer
7.7 Silicon
7.8 Other Materials
8 Global Microneedle Drug Delivery Systems Market, By Application
8.1 Introduction
8.2 Cancer Therapy
8.3 Dermatology
8.4 Hormone Delivery
8.5 Insulin Delivery
8.6 Oncology
8.7 Pain Management
8.8 Pediatric Medicine
8.9 Transdermal Drug Delivery
8.10 Vaccine Delivery
8.11 Other Applications
9 Global Microneedle Drug Delivery Systems Market, By End User
9.1 Introduction
9.2 Pharmacies
9.3 Hospitals
9.4 Healthcare Providers
9.5 Other End Users
10 Global Microneedle Drug Delivery Systems Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 3M
12.2 3D-Micromac AG
12.3 Becton, Dickinson and Company
12.4 Candela Corporation
12.5 Clearside Biomedical, Inc.
12.6 Corium Inc.
12.7 Dermaroller GmbH
12.8 Dynatrace
12.9 Genex Technologies
12.10 Georgia Institute of Technology
12.11 Innoture Medical Technology Limited
12.12 LTS Lohmann Therapie-Systeme AG
12.13 Micron Biomedical Inc.
12.14 Micropoint Technologies
12.15 My Life Technologies
12.16 NanoSmart Pharmaceuticals, Inc.
12.17 Nitto Denko Corporation
12.18 PreCelleon Medical Inc.
12.19 Rani Therapeutics
12.20 Raphas Co. Ltd
12.21 TheraJect Inc.
12.22 Transdermal Technologies, Inc.
12.23 Valeritas, Inc.
12.24 Vaxess Technologies
12.25 Zosano Pharma
12.26 Zydis
List of Tables
1 Global Microneedle Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
2 Global Microneedle Drug Delivery Systems Market Outlook, By Component (2021-2030) ($MN)
3 Global Microneedle Drug Delivery Systems Market Outlook, By Coated Microneedle Technology (2021-2030) ($MN)
4 Global Microneedle Drug Delivery Systems Market Outlook, By Hollow Microneedle Technology (2021-2030) ($MN)
5 Global Microneedle Drug Delivery Systems Market Outlook, By Solid Microneedle Technology (2021-2030) ($MN)
6 Global Microneedle Drug Delivery Systems Market Outlook, By Other Components (2021-2030) ($MN)
7 Global Microneedle Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
8 Global Microneedle Drug Delivery Systems Market Outlook, By Dissolving Microneedle Technology (2021-2030) ($MN)
9 Global Microneedle Drug Delivery Systems Market Outlook, By Porous Microneedles (2021-2030) ($MN)
10 Global Microneedle Drug Delivery Systems Market Outlook, By 3D-Printed Microneedles (2021-2030) ($MN)
11 Global Microneedle Drug Delivery Systems Market Outlook, By Hydrogel Microneedles (2021-2030) ($MN)
12 Global Microneedle Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
13 Global Microneedle Drug Delivery Systems Market Outlook, By Material (2021-2030) ($MN)
14 Global Microneedle Drug Delivery Systems Market Outlook, By Biodegradable Microneedle Materials (2021-2030) ($MN)
15 Global Microneedle Drug Delivery Systems Market Outlook, By Ceramics (2021-2030) ($MN)
16 Global Microneedle Drug Delivery Systems Market Outlook, By Metal (2021-2030) ($MN)
17 Global Microneedle Drug Delivery Systems Market Outlook, By Metal Alloys (2021-2030) ($MN)
18 Global Microneedle Drug Delivery Systems Market Outlook, By Polymer (2021-2030) ($MN)
19 Global Microneedle Drug Delivery Systems Market Outlook, By Silicon (2021-2030) ($MN)
20 Global Microneedle Drug Delivery Systems Market Outlook, By Other Materials (2021-2030) ($MN)
21 Global Microneedle Drug Delivery Systems Market Outlook, By Application (2021-2030) ($MN)
22 Global Microneedle Drug Delivery Systems Market Outlook, By Cancer Therapy (2021-2030) ($MN)
23 Global Microneedle Drug Delivery Systems Market Outlook, By Dermatology (2021-2030) ($MN)
24 Global Microneedle Drug Delivery Systems Market Outlook, By Hormone Delivery (2021-2030) ($MN)
25 Global Microneedle Drug Delivery Systems Market Outlook, By Insulin Delivery (2021-2030) ($MN)
26 Global Microneedle Drug Delivery Systems Market Outlook, By Oncology (2021-2030) ($MN)
27 Global Microneedle Drug Delivery Systems Market Outlook, By Pain Management (2021-2030) ($MN)
28 Global Microneedle Drug Delivery Systems Market Outlook, By Pediatric Medicine (2021-2030) ($MN)
29 Global Microneedle Drug Delivery Systems Market Outlook, By Transdermal Drug Delivery (2021-2030) ($MN)
30 Global Microneedle Drug Delivery Systems Market Outlook, By Vaccine Delivery (2021-2030) ($MN)
31 Global Microneedle Drug Delivery Systems Market Outlook, By Other Applications (2021-2030) ($MN)
32 Global Microneedle Drug Delivery Systems Market Outlook, By End User (2021-2030) ($MN)
33 Global Microneedle Drug Delivery Systems Market Outlook, By Pharmacies (2021-2030) ($MN)
34 Global Microneedle Drug Delivery Systems Market Outlook, By Hospitals (2021-2030) ($MN)
35 Global Microneedle Drug Delivery Systems Market Outlook, By Healthcare Providers (2021-2030) ($MN)
36 Global Microneedle Drug Delivery Systems Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.